DreaMed Diabetes is a startup based in Israel, most recent round Series-c-plus, 1 tracked investor.
DreaMed Diabetes is a company founded in 2014 headquartered in Israel. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
DreaMed Diabetes develops AI-powered decision support systems for insulin dose optimization. Their cloud-based platform helps healthcare providers manage diabetes patients more effectively.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.